|
Volumn 30, Issue 8, 1998, Pages 4163-4165
|
Prolongation of concordant xenograft survival by treatment with FTY720
a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
FINGOLIMOD;
TACROLIMUS;
ANIMAL EXPERIMENT;
B LYMPHOCYTE;
CELL VIABILITY;
CONFERENCE PAPER;
DOSE RESPONSE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG POTENTIATION;
GRAFT SURVIVAL;
HAMSTER;
HEMATOCRIT;
HUMAN;
HUMAN CELL;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAMUSCULAR DRUG ADMINISTRATION;
LEUKOCYTE COUNT;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RAT;
T LYMPHOCYTE;
XENOGRAFT;
XENOTRANSPLANTATION;
ADMINISTRATION, ORAL;
ANIMALS;
B-LYMPHOCYTES;
CRICETINAE;
GRAFT SURVIVAL;
HEART TRANSPLANTATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LIVER TRANSPLANTATION;
LYMPHOCYTE DEPLETION;
MESOCRICETUS;
PROPYLENE GLYCOLS;
RATS;
RATS, INBRED LEW;
SKIN TRANSPLANTATION;
SPHINGOSINE;
T-LYMPHOCYTES;
TRANSPLANTATION, HETEROLOGOUS;
|
EID: 0032427828
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)01379-7 Document Type: Conference Paper |
Times cited : (8)
|
References (5)
|